MediaPress Releases Archives Media Inquiries In the News Press Releases FEATURED PRESS RELEASE September 14, 2026Tris Pharma Introduces New 30-Count Bottle Size for QuilliChew ER® (methylphenidate HCl) Extended-Release Chewable Tablets for Attention Deficit Hyperactivity Disorder (ADHD) September 3, 2026Adneuris Therapeutics to Present at PAINWeek 2026 September 1, 2026Tris Pharma to Showcase ADHD Leadership and Commitment to Individualized Care at Fall 2026 Medical Conferences August 12, 2026Tris Pharma Expands Support for People Living with ADHD Through New Partnerships with Calm Health and ADHD Central August 5, 2026Adneuris Therapeutics Grants Exclusive License to Maruishi Pharmaceutical to Advance Cebranopadol in Japan and South Korea
